Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization

Nature Chemical Biology

Volumn 8, Issue 7, 2012, Pages 655-660

  Stanger, Karen ^a   Steffek, Micah ^a   Zhou, Lijuan ^a   Pozniak, Christine D ^a   Quan, Clifford ^a   Franke, Yvonne ^a   Tom, Jeff ^a   Tam, Christine ^a   Elliott, J Michael ^a   Lewcock, Joseph W ^a   Zhang, Yingnan ^a   Murray, Jeremy ^a   Hannoush, Rami N ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 6; ENZYME PRECURSOR;

ALLOSTERISM; ARTICLE; DEGENERATIVE DISEASE; DRUG TARGETING; HUMAN; IN VITRO STUDY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 84862882878     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.967     Document Type: Article

References (48)

1. Alnemri, E.S. et al. Human ICE/CED-3 protease nomenclature. Cell 87, 171 (1996).
2. Denault, J.B. & Salvesen, G.S. Caspases: keys in the ignition of cell death. Chem. Rev. 102, 4489-4500 (2002).
3. Riedl, S.J. & Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897-907 (2004).
4. Talanian, R.V. et al. Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682 (1997).
5. Stennicke, H.R., Renatus, M., Meldal, M. & Salvesen, G.S. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350, 563-568 (2000).
6. Stennicke, H.R. & Salvesen, G.S. Caspases-controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477, 299-306 (2000).
7. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470 (2002).
8. Salvesen, G. Caspases: cell signaling by proteolysis. in Handbook of Cell Signaling 2nd edn (eds. Bradshaw, R.A. & Dennis, E.A.) 1297-1302 (Elsevier Inc., 2010).
9. Riedl, S.J. et al. Structural basis for the activation of human procaspase-7. Proc. Natl. Acad. Sci. USA 98, 14790-14795 (2001).
10. Chai, J. et al. Crystal structure of a procaspase-7 zymogen. Mechanisms of activation and substrate binding. Cell 107, 399-407 (2001).
11. Wang, X.J. et al. Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep. 11, 841-847 (2010).
12. Boatright, K.M. et al. A unified model for apical caspase activation. Mol. Cell 11, 529-541 (2003).
13. Sohn, D., Schulze-Osthoff, K. & Janicke, R.U. Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. J. Biol. Chem. 280, 5267-5273 (2005).
14. Yu, J.W., Jeffrey, P.D. & Shi, Y. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl. Acad. Sci. USA 106, 8169-8174 (2009).
15. Salvesen, G.S. & Dixit, V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96, 10964-10967 (1999).
16. Pop, C. & Salvesen, G.S. Human caspases: activation, specificity, and regulation. J. Biol. Chem. 284, 21777-21781 (2009).
17. Shi, Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 13, 1979-1987 (2004).
18. Albrecht, S., Bogdanovic, N., Ghetti, B., Winblad, B. & LeBlanc, A.C. Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin I or presenilin II mutations. J. Neuropathol. Exp. Neurol. 68, 1282-1293 (2009).
19. Albrecht, S. et al. Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol. 170, 1200-1209 (2007).
20. Guo, H. et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165, 523-531 (2004).
21. Klaiman, G., Petzke, T.L., Hammond, J. & Leblanc, A.C. Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol. Cell. Proteomics 7, 1541-1555 (2008).
22. Nikolaev, A., McLaughlin, T., O'Leary, D.D. & Tessier-Lavigne, M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989 (2009).
23. Wellington, C.L. et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862-7872 (2002).
24. Graham, R.K. et al. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J. Neurosci. 30, 15019-15029 (2010).
25. Graham, R.K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179-1191 (2006).
26. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
27. Hermel, E. et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 11, 424-438 (2004).
28. Linton, S.D. Caspase inhibitors: a pharmaceutical industry perspective. Curr. Top. Med. Chem. 5, 1697-1717 (2005).
29. Callus, B.A. & Vaux, D.L. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 14, 73-78 (2007).
30. Datta, D., Scheer, J.M., Romanowski, M.J. & Wells, J.A. An allosteric circuit in caspase-1. J. Mol. Biol. 381, 1157-1167 (2008).
31. Hardy, J.A., Lam, J., Nguyen, J.T., O'Brien, T. & Wells, J.A. Discovery of an allosteric site in the caspases. Proc. Natl. Acad. Sci. USA 101, 12461-12466 (2004).
32. Scheer, J.M., Romanowski, M.J. & Wells, J.A. A common allosteric site and mechanism in caspases. Proc. Natl. Acad. Sci. USA 103, 7595-7600 (2006).
33. Chai, J. et al. Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 107, 399-407 (2001).
34. Smith, C.K. & Regan, L. Guidelines for protein design: the energetics of â sheet side chain interactions. Science 270, 980-982 (1995).
35. Orth, K., Chinnaiyan, A.M., Garg, M., Froelich, C.J. & Dixit, V.M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271, 16443-16446 (1996).
36. Takahashi, A. et al. Cleavage of lamin A by Mch2 but not CPP32: multiple ICE-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 93, 8395-8400 (1996).
37. Slee, E.A., Adrain, C. & Martin, S.J. Executioner caspase-3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326 (2001).
38. Ruchaud, S. et al. Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J. 21, 1967-1977 (2002).
39. Mintzer, R. et al. A whole cell assay to measure caspase-6 activity by detecting cleavage of Lamin A/C. PLoS ONE 7, e30376 (2012).
40. Williams, S.T., Smith, A.N., Cianci, C.D., Morrow, J.S. & Brown, T.L. Identification of the primary caspase 3 cleavage site in alpha II-spectrin during apoptosis. Apoptosis 8, 353-361 (2003).
41. Germain, M. et al. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. J. Biol. Chem. 274, 28379-28384 (1999).
42. Xu, G. et al. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 410, 494-497 (2001).
43. Klaiman, G., Champagne, N. & LeBlanc, A.C. Self-activation of caspase-6 in vitro and in vivo: caspase-6 activation does not induce cell death in HEK293T cells. Biochim. Biophys. Acta 1793, 592-601 (2009).
44. Salvesen, G.S. & Duckett, C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410 (2002).
45. Vaux, D.L. & Silke, J. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6, 287-297 (2005).
46. Vaidya, S., Velazquez-Delgado, E.M., Abbruzzese, G. & Hardy, J.A. Substrate-induced conformational changes occur in all cleaved forms of caspase-6. J. Mol. Biol. 406, 75-91 (2011).
47. Kunkel, T.A., Roberts, J.D. & Zakour, R.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154, 367-382 (1987).
48. Zhang, Y. et al. Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat. Chem. Biol. 5, 217-219 (2009).